Varianti del gene MC1R in Puglia e analisi di altri fattori di rischio per il melanoma
Gabriella Guida(University of Bari Aldo Moro), Michele Guida(Istituto Tumori Bari), Letizia Porcelli(Istituto Tumori Bari), Stefania Guida(Vita-Salute San Raffaele University), Amalia Azzariti(Istituto Tumori Bari), Rossella Labarile(Institute for Chemical and Physical Processes), Sabino Strippoli(Istituto Tumori Bari), Anna Albano(Istituto Tumori Bari), Stefania Tommasi(Istituto Tumori Bari), Raffaele Filotico(University of Bari Aldo Moro), Immacolata Maida(University of Bari Aldo Moro)
CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro)
January 1, 2013
Cited by 0
Related Papers
Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated <i>BRAF</i>-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial
|Journal of Clinical Oncology|2022|231
Accuracy in melanoma detection: A 10-year multicenter survey
|Journal of the American Academy of Dermatology|2011|209
The E6 and E7 Proteins of the Cutaneous Human Papillomavirus Type 38 Display Transforming Properties
|Journal of Virology|2003|187
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort
|Journal of Translational Medicine|2014|164